These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2702665)

  • 1. Interactions of the phenylpyrazolo steroid cortivazol with glucocorticoid receptors in steroid-sensitive and -resistant human leukemic cells.
    Thompson EB; Srivastava D; Johnson BH
    Cancer Res; 1989 Apr; 49(8 Suppl):2253s-2258s. PubMed ID: 2702665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two glucocorticoid binding sites on the human glucocorticoid receptor.
    Srivastava D; Thompson EB
    Endocrinology; 1990 Oct; 127(4):1770-8. PubMed ID: 2205477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
    Miller AL; Webb MS; Thompson EB
    Steroids; 2007 Sep; 72(9-10):673-81. PubMed ID: 17606285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.
    Ashraf J; Kunapuli S; Chilton D; Thompson EB
    J Steroid Biochem Mol Biol; 1991 May; 38(5):561-8. PubMed ID: 2039752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor.
    Schlechte JA; Simons SS; Lewis DA; Thompson EB
    Endocrinology; 1985 Oct; 117(4):1355-62. PubMed ID: 4029081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of [3H]cortivazol to characterize glucocorticoid receptors in a dexamethasone-resistant human leukemic cell line.
    Schlechte JA; Schmidt TJ
    J Clin Endocrinol Metab; 1987 Mar; 64(3):441-6. PubMed ID: 2880860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
    Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-resistant human acute lymphoblastic leukemic cell line with functional receptor.
    Zawydiwski R; Harmon JM; Thompson EB
    Cancer Res; 1983 Aug; 43(8):3865-73. PubMed ID: 6134583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding studies of RU486 in different Reuber hepatoma variants.
    Chasserot-Golaz S; Beck G
    Receptor; 1993; 3(1):31-7. PubMed ID: 8348081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid versus antiglucocorticoid activity: can a single functional group modification of glucocorticoid steroids always convey antiglucocorticoid activity?
    Lamontagne N; Mercier L; Pons M; Thompson EB; Simons SS
    Endocrinology; 1984 Jun; 114(6):2252-63. PubMed ID: 6547091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-glucocorticoid receptor-mediated effects of the potent glucocorticoid deacylcortivazol.
    Harmon JM; Schmidt TJ; Thompson EB
    Cancer Res; 1982 Jun; 42(6):2110-4. PubMed ID: 6951631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.
    Yoshikawa N; Yamamoto K; Shimizu N; Yamada S; Morimoto C; Tanaka H
    Mol Endocrinol; 2005 May; 19(5):1110-24. PubMed ID: 15677712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
    Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
    J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells.
    Powers JH; Hillmann AG; Tang DC; Harmon JM
    Cancer Res; 1993 Sep; 53(17):4059-65. PubMed ID: 8358735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
    Styczynski J; Kurylak A; Wysocki M
    Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding and regulatory actions of dexamethasone-type I receptor complexes in mouse brain.
    Luttge WG; Davda MM; Rupp ME; Kang CG
    Endocrinology; 1989 Sep; 125(3):1194-203. PubMed ID: 2759022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptors in human leukemias and related diseases.
    Thompson EB; Smith JR; Bourgeois S; Harmon JM
    Klin Wochenschr; 1985 Aug; 63(15):689-98. PubMed ID: 2413243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
    Hala M; Hartmann BL; Böck G; Geley S; Kofler R
    Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.
    Ashraf J; Thompson EB
    Mol Endocrinol; 1993 May; 7(5):631-42. PubMed ID: 8316249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.